Soochan Bae, Ph.D.
Affiliations: | 2005 | Loma Linda University, Loma Linda, United States |
Area:
PharmacologyGoogle:
"Soochan Bae"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Lubo Zhang | grad student | 2005 | Loma Linda University | |
| (Prenatal cocaine exposure and cardiac programming.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mahmood E, Bae S, Chaudhary O, et al. (2020) Neuropeptide Y incorporated into PVAX nanoparticle improves angiogenesis in a murine model of myocardial ischemia. European Journal of Pharmacology. 173261 |
| Eshun D, Saraf R, Bae S, et al. (2017) Neuropeptide Y3-36 Incorporated Into PVAX Nanoparticle Improves Functional Blood Flow In A Murine Model Of Hind Limb Ischemia. Journal of Applied Physiology (Bethesda, Md. : 1985). jap.00467.2016 |
| Bae S, Park M, Kang C, et al. (2016) Hydrogen Peroxide-Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury. Journal of the American Heart Association. 5 |
| Lee D, Park S, Bae S, et al. (2015) Hydrogen peroxide-activatable antioxidant prodrug as a targeted therapeutic agent for ischemia-reperfusion injury. Scientific Reports. 5: 16592 |
| Ke Q, Samad MA, Bae S, et al. (2015) Exaggerated hypertensive response to combretastatin A-4 phosphate in hypertensive rats: Effective pharmacological inhibition by diltiazem. Vascular Pharmacology |
| Park S, Yoon J, Bae S, et al. (2014) Therapeutic use of H2O2-responsive anti-oxidant polymer nanoparticles for doxorubicin-induced cardiomyopathy. Biomaterials. 35: 5944-53 |
| Lee D, Bae S, Hong D, et al. (2013) H2O2-responsive molecularly engineered polymer nanoparticles as ischemia/reperfusion-targeted nanotherapeutic agents. Scientific Reports. 3: 2233 |
| Bae S, Singh SS, Yu H, et al. (2013) Vitamin D signaling pathway plays an important role in the development of heart failure after myocardial infarction. Journal of Applied Physiology (Bethesda, Md. : 1985). 114: 979-87 |
| Choi JH, Ke Q, Bae S, et al. (2011) Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats. Journal of Cardiac Failure. 17: 1051-8 |
| Bae S, Yalamarti B, Ke Q, et al. (2011) Preventing progression of cardiac hypertrophy and development of heart failure by paricalcitol therapy in rats. Cardiovascular Research. 91: 632-9 |